help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0190
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/516    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipfert, L.
Right arrow Articles by Reszka, A. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipfert, L.
Right arrow Articles by Reszka, A. A.
Molecular Endocrinology 20 (3): 516-533
Copyright © 2006 by The Endocrine Society

Antagonist-Induced, Activation Function-2-Independent Estrogen Receptor {alpha} Phosphorylation

Lorraine Lipfert, John E. Fisher, Nan Wei, Angela Scafonas, Qin Su, Joel Yudkovitz, Fang Chen, Sudha Warrier, Elizabeth T. Birzin, Seongkon Kim, Helen Y. Chen, Qiang Tan, Azriel Schmidt, Frank Dininno, Susan P. Rohrer, Milton L. Hammond, Gideon A. Rodan, Leonard P. Freedman and Alfred A. Reszka

Department of Molecular Endocrinology and Bone Biology, Merck Research Laboratories (L.L., J.E.F., N.W., A.S., Q.S., J.Y., F.C., S.W., E.T.B., A.S., S.P.R., L.P.F., A.A.R.), West Point, Pennsylvania 19486; Department of Medicinal Chemistry, Merck Research Laboratories (S.K., H.Y.C., Q.T., F.D., M.L.H.), Rahway, New Jersey 07065; and Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine (G.A.R.), Philadelphia, Pennsylvania 19104

Address all correspondence and requests for reprints to: Dr. Alfred Reszka, Molecular Endocrinology and Bone Biology, Merck Research Laboratories, WP26A-1000, West Point, Pennsylvania 19486.

Estrogen receptor {alpha} (ER{alpha}) serine 118 (Ser118) phosphorylation modulates activation function-1 (AF1) function. Correct positioning of helix 12 promotes agonist-dependent recruitment of cyclin-dependent kinase-7 to catalyze this event. In this study we show robust cyclin-dependent kinase-7-independent, AF2 antagonist-induced Ser118 phosphorylation. Estradiol (E2) and ICI-182,780 (ICI-780) induce Ser118 phosphorylation of wild-type ER{alpha} and either of two helix 12 mutants, suggesting AF2-independent action, probably via shedding of 90-kDa heat shock protein. With E2 treatment, the predominantly nuclear, phosphorylated ER{alpha} in COS-1 cells is detergent soluble. Although levels of ICI-780-induced phosphorylation are profound, Ser118-phosphorylated ER{alpha} is aggregated over the nucleus or in the cytoplasm, fractionating with the cell debris and making detection in cleared lysates improbable. Selective ER modulators (SERMs) elicit a mixed response with phosphorylated ER{alpha} in both detergent-soluble and -insoluble compartments. Apparent ligand-induced loss of ER{alpha} protein from cleared lysates is thus due to ligand-induced redistribution into the pellet, not degradation. The COS-1 response to ICI-780 can be mimicked in MCF-7 cells treated with a proteasome inhibitor to block authentic ligand-induced degradation. With SERMs and antagonists, the magnitude of Ser118-phosphorylated receptor redistribution into the insoluble fraction of COS-1 cells correlates with the magnitude of authentic ER{alpha} degradation in MCF-7 cells. A strong inverse correlation with ligand-induced uterotropism in vivo (P < 0.0001) and direct correlation with AF2-independent transrepression of the matrix metalloprotease-1 promoter in endometrial cells in vitro are seen. These data suggest that ligand-induced Ser118 phosphorylation of ER{alpha} can be AF2 independent. Furthermore, they identify translocation of Ser118-phosphorylated ER{alpha} out of the nucleus, leading to cytoplasmic aggregation, as an antagonist pathway that may precede receptor degradation.

NURSA Molecule Pages Link:

Nuclear Receptors:   ERα
Ligands:   17β-Estradiol  |  4-Hydroxytamoxifen  |  Raloxifene



This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
M. De los Santos, O. Martinez-Iglesias, and A. Aranda
Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells
Endocr. Relat. Cancer, December 1, 2007; 14(4): 1021 - 1028.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Zheng, A. Kallio, and P. Harkonen
Tamoxifen-Induced Rapid Death of MCF-7 Breast Cancer Cells Is Mediated via Extracellularly Signal-Regulated Kinase Signaling and Can Be Abrogated by Estrogen
Endocrinology, June 1, 2007; 148(6): 2764 - 2777.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Wang, W. Chen, E. Kono, T. Dang, and M. J. Garabedian
Modulation of Glucocorticoid Receptor Phosphorylation and Transcriptional Activity by a C-Terminal-Associated Protein Phosphatase
Mol. Endocrinol., March 1, 2007; 21(3): 625 - 634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society